Evidence map›Paper›PMID 42616863›Full record

ArticleScience advances2026

Ptpn2 limits plasma cell fate and antiviral immunity by integrating B cell receptor and IFN-γ signals in B cells.

Ana Maria Hincapie, Alexandre Poirier, Isabelle Aubry, Philippe Aumont, Aanya Bhagrath, Noriko Uetani, Bianca Colalillo, Chenyue Wu, Benoit Charbonneau, Stephanie Bussieres-Marmen and 6 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ana Maria HincapieDepartment of Biochemistry, McGill University, Montreal, QC, Canada.ORCID 0009-0000-7725-3039
Alexandre PoirierGoodman Cancer Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0002-6754-6003
Isabelle AubryGoodman Cancer Institute, McGill University, Montreal, QC, Canada.ORCID 0009-0004-5295-7418
Philippe AumontGoodman Cancer Institute, McGill University, Montreal, QC, Canada.
Aanya BhagrathDepartment of Physiology, McGill University, Montreal, QC, Canada.ORCID 0000-0003-0764-9745
Noriko UetaniGoodman Cancer Institute, McGill University, Montreal, QC, Canada.
Bianca ColalilloDepartment of Biochemistry, McGill University, Montreal, QC, Canada.
Chenyue WuGoodman Cancer Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0002-5059-1828
Benoit CharbonneauMcGill University Research Centre on Complex Traits, Montreal, QC, Canada.
Stephanie Bussieres-MarmenGoodman Cancer Institute, McGill University, Montreal, QC, Canada.ORCID 0009-0006-9397-8121
Belma M AbidinGoodman Cancer Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0002-1406-1344
Javier M Di NoiaDepartment of Microbiology and Immunology, Montreal, QC, Canada.ORCID 0000-0003-2896-0321
Judith N MandlDepartment of Physiology, McGill University, Montreal, QC, Canada.ORCID 0000-0002-6512-3437
Silvia M VidalMcGill University Research Centre on Complex Traits, Montreal, QC, Canada.ORCID 0000-0002-4069-4276
Jorg H FritzMcGill University Research Centre on Complex Traits, Montreal, QC, Canada.ORCID 0000-0003-3411-1238
Michel L TremblayDepartment of Biochemistry, McGill University, Montreal, QC, Canada.ORCID 0000-0002-0281-541X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antigen-specific humoral responses are critical for long-term protection against infectious diseases, yet the mechanisms that regulate B cell differentiation and antibody production remain incompletely defined. Here, we identify the Protein Tyrosine Phosphatase Nonreceptor Type 2 (Ptpn2) as a B cell-intrinsic regulator of plasma cell fate and isotype switching. Using a B cell-specific Ptpn2 knockout mouse model, we show that Ptpn2 restrains both B cell receptor and interferon-γ (IFN-γ) signaling by directly dephosphorylating Lyn, STAT1, and STAT3. Loss of Ptpn2 leads to hyperactivation of these two signaling pathways, resulting in transcriptional reprogramming that promotes plasma cell differentiation and increased IFN-γ-driven antibody production. Functionally, Ptpn2-deficient mice generated enhanced primary antiviral antibody responses following influenza infection and elevated virus-specific and neutralizing titers upon recall without compromising affinity. These findings identify Ptpn2 as a key intracellular checkpoint that integrates antigenic and inflammatory cues to regulate humoral immunity, with potential implications for enhancing vaccine-induced protective immunity.

Indexed as

B-LymphocytesInterferon-gammaPlasma CellsProtein Tyrosine Phosphatase, Non-Receptor Type 2Signal TransductionAnimalsCell DifferentiationImmunity, HumoralMiceMice, KnockoutOrthomyxoviridae InfectionsSTAT1 Transcription FactorInterferon-gammaProtein Tyrosine Phosphatase, Non-Receptor Type 2Ptpn2 protein, mouseSTAT1 Transcription Factor

Identifiers

PMID42616863
PMCPMC13488884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.